Shao ZM - Search Results

1

Large-scale genomic sequencing reveals adaptive opportunity of targeting mutated-PI3Kα in early and advanced HER2-positive breast cancer.

Guo LW, Li XG, Yang YS, Lu XX, Han XC, Lang GT, Chen L, Shao ZM, Hu X. Guo LW, et al. Among authors: shao zm. Clin Transl Med. 2021 Nov;11(11):e589. doi: 10.1002/ctm2.589. Clin Transl Med. 2021. PMID: 34842356 Free PMC article.

2

Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.

Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM. Fu DY, et al. Among authors: shao zm. Hum Pathol. 2010 Jan;41(1):48-58. doi: 10.1016/j.humpath.2009.06.007. Epub 2009 Sep 5. Hum Pathol. 2010. PMID: 19733895

3

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.

Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin WJ, Wu J, Shao ZM. Jin W, et al. Among authors: shao zm. Breast Cancer Res Treat. 2010 Sep;123(2):359-73. doi: 10.1007/s10549-009-0652-2. Epub 2009 Nov 27. Breast Cancer Res Treat. 2010. PMID: 19943104

4

Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.

Jin W, Liu Y, Chen L, Zhu H, Di GH, Ling H, Wu J, Shao ZM. Jin W, et al. Among authors: shao zm. Breast Cancer Res Treat. 2011 Feb;125(3):699-713. doi: 10.1007/s10549-010-0876-1. Epub 2010 Apr 3. Breast Cancer Res Treat. 2011. PMID: 20364308

5

Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy.

Chen XS, Wu JY, Huang O, Chen CM, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW. Chen XS, et al. Among authors: shao zm. Oncol Rep. 2010 May;23(5):1213-20. doi: 10.3892/or_00000752. Oncol Rep. 2010. PMID: 20372832

6

ERβ and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells.

Chen Y, Chen L, Li JY, Mukaida N, Wang Q, Yang C, Yin WJ, Zeng XH, Jin W, Shao ZM. Chen Y, et al. Among authors: shao zm. Cancer Biol Ther. 2011 Mar 1;11(5):497-511. doi: 10.4161/cbt.11.5.14667. Epub 2011 Mar 1. Cancer Biol Ther. 2011. PMID: 21266854 Free article.

7

Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer.

Chen S, Chen CM, Yu KD, Zhou RJ, Shao ZM. Chen S, et al. Among authors: shao zm. Ann Surg Oncol. 2012 Sep;19(9):3002-11. doi: 10.1245/s10434-012-2318-2. Epub 2012 Mar 22. Ann Surg Oncol. 2012. PMID: 22437200

8

Association of HER-2 copy number and HER-2/CEP-17 ratio with neoadjuvant taxane-containing chemotherapy sensitivity in locally advanced breast cancer.

Yu KD, Liu GY, Zhou XY, Zhou Y, Wu J, Chen CM, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: shao zm. Oncologist. 2012;17(6):792-800. doi: 10.1634/theoncologist.2011-0381. Epub 2012 May 4. Oncologist. 2012. PMID: 22561335 Free PMC article.

9

Polymorphism rs4919510:C>G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes.

Huang AJ, Yu KD, Li J, Fan L, Shao ZM. Huang AJ, et al. Among authors: shao zm. PLoS One. 2012;7(5):e35252. doi: 10.1371/journal.pone.0035252. Epub 2012 May 7. PLoS One. 2012. PMID: 22586447 Free PMC article.

10

The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer.

Chen S, Huang L, Liu Y, Chen CM, Wu J, Shao ZM. Chen S, et al. Among authors: shao zm. Eur J Surg Oncol. 2013 Jun;39(6):619-26. doi: 10.1016/j.ejso.2013.02.019. Epub 2013 Mar 7. Eur J Surg Oncol. 2013. PMID: 23473851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters